Description Module

Description Module

The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.

Description Module path is as follows:

Study -> Protocol Section -> Description Module

Description Module


Ignite Creation Date: 2025-12-24 @ 7:35 PM
Ignite Modification Date: 2025-12-24 @ 7:35 PM
NCT ID: NCT03441503
Brief Summary: The goal of this study is to identify effective ways to assess the patient and family experience. Specifically, the study will examine automated administration of the Child Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) Survey on the day of discharge through an electronic interactive patient care system. The will be a multisite study that will take place at Boston Children's Hospital (BCH) as well as at several other hospitals across the United States.
Detailed Description: Preliminary research conducted by BCH on alternative administration methods of Child HCAHPS has proven promising. Specifically, a pilot of administration on the day of discharge using tablet computers increased response rates, especially among hard to reach groups. To further explore modes of Child HCAHPS day of discharge administration, the Center of Excellence for Pediatric Quality Measurement (CEPQM) at BCH is collaborating with GetWellNetwork (GetWell), a company that provides interactive education material for patient televisions, to enable parents and guardians to complete Child HCAHPS on the day of discharge from the inpatient television. For this multisite study, parents of hospitalized children from BCH and participating sites will be randomized at the time of discharge to either receiving Child HCAHPS on the day of discharge on the inpatient television or standard Child HCAHPS administration via mail or email. The study will continue for up to six months at each participating site.
Study: NCT03441503
Study Brief:
Protocol Section: NCT03441503